Deputy directors at the FDA center that oversees the regulation of cancer drugs plan to leave, adding to a flood of top ...

On March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate ...

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

Researchers analyzed pivotal and confirmatory trial characteristics, outcomes, and safety data for 102 cancer drug ...

This week, in response to President Trump's ongoing cuts to scientific research and staffing at federal agencies, nearly ...

The Trump administration's cuts to the National Institutes of Health has some worried about stalls in research and medicine.

The cuts were part of a Trump administration plan announced last week to dismiss thousands of employees and drastically ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...

In the nearly three years since Chandler Nelson died from a rare form of pediatric cancer, his parents haven’t forgotten the ...

Misinformation about ivermectin as a cancer treatment is on the rise, with social media and public figures fueling false ...

Li Ka Shing Foundation and Temasek Trust have committed $12 million to conduct histotripsy trials here. Read more at ...

Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.